<DOC>
	<DOC>NCT02810821</DOC>
	<brief_summary>Deficiency in gonadal hormone has been considered to play a role in ageing related increased incidence of cardiovascular events. But the mechanism has not been fully elucidated. On the other hand, the dramatic increase in gonadotropin level didn't drew much attention when talking about the increased risk of cardiovascular disease during menopausal transition. This study aim to investigate the association between gonadal hormone, gonadotropin and long-term cardiovascular events.</brief_summary>
	<brief_title>Gonadal Hormone, Gonadotropin and Cardiovascular Events</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>Male or female with intact uterus and at least one ovary Aged of 18 to 75 years old; Pregnancy or lactation women; Presence of pituitary/hypothalamic disorders, polycystic ovarian syndrome or other endocrinal and metabolic disorders that known to compromise hypothalamicpituitarygonadal function; Receiving psychotropic or hormonal medications including hormonal contraception and hormone therapies; Taking lipidlowering agents or hypoglycemic agents and other drugs that known to influence cardiovascular health; Obviously poor compliance.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Gonadal hormones</keyword>
	<keyword>Gonadotropins</keyword>
	<keyword>Cardiovascular diseases</keyword>
	<keyword>Lipids</keyword>
	<keyword>Obesity</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Glucose metabolism disorders</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Non-alcoholic fatty liver disease</keyword>
</DOC>